U.S. federal trademark · Serial No. 98176909 · Reg. No. TMA1304634
Drug delivery agent in the form of an intracellular enhancer in the nature of compounds that facilitate delivery of a wide range of pharmaceuticals; medicinal preparations for use in oncology; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; vaccines for human use
Antibody testing, namely, antibody profiling for scientific research purposes; research and development of vaccines and medicines; scientific research for medical purposes in the field of oncology
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.